4.7 Article

Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors

期刊

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2021.154706

关键词

Blood coagulation; Coronary artery calcification; Inflammation; Lipoprotein (a); Multi-Ethnic Study of Atherosclerosis

资金

  1. Australian National Health and Medical Research Council Career Development Fellowship [1122854]
  2. National Heart, Lung, and Blood institute [75N92020D00001, HHSN2682015000031, NO1-HC-95159, 75N92020D00005, NO1-HC-95160, 75N92020D00002, NO1-HC-95161, 75N92020D00003, NO1-HC-95162, 75N92020D00006]
  3. National Center for Advancing Translational Sciences [UL1-TR-000040, ULl-TR-001079, UU-TR-001420]
  4. U.S Environmental Protection Agency (EPA) [RD831697, RD -83830001]
  5. The National Heart, Lung, and Blood institute [NO1-HC-95163, 75N92020D00004, NO1-HC-95164, 75N92020D00007, NO1-HC-95165, NO1-HC-95166, NO1-HC-95167, NO1-HC-95168, NO1-HC-95169]

向作者/读者索取更多资源

This study examined the relationship between Lp(a) and CAC, finding that elevated Lp(a) was significantly associated with an absolute increase in CAC volume. This association was more pronounced in participants with higher levels of inflammation and coagulation markers.
Background: Elevated plasma lipoprotein (a) [Lp(a)] and coronary artery calcification (CAC) are established cardiovascular risk factors that correlate with each other. We hypothesized that other cardiovascular risk factors could affect their relationship. Methods: We tested for interactions of 24 study variables related to dyslipidemia, diabetes, insulin resistance, hypertension, inflammation and coagulation with baseline Lp(a) on change in CAC volume and density over 9.5 years in 5975 Multi-Ethnic Study of Atherosclerosis (MESA) participants, free of apparent cardiovascular disease at baseline. Results: Elevated Lp(a) was associated with larger absolute increase in CAC volume (3.21 and 4.45 mm(3)/year higher for Lp(a) >= 30 versus <30 mg/dL, and Lp(a) >= 50 versus <50 mg/dL, respectively), but not relative change in CAC volume. No association was found with change in CAC density when assessing continuous ln-transformed Lp(a). The association between elevated Lp(a) (>= 30 mg/dL) and absolute change in CAC volume was greater in participants with higher circulating levels of interleukin-2 soluble receptor alpha, soluble tumor necrosis factor alpha receptor 1 and fibrinogen (15.33, 11.81 and 7.02 mm(3)/year in quartile 4, compared to -3.44, -0.59 and 1.91 mm(3)/year in quartile 1, respectively). No significant interaction was found for other study variables. Similar interactions were seen when assessing Lp(a) levels >= 50 mg/dL. Conclusions: Elevated Lp(a) was associated with an absolute increase in CAC volume, especially in participants with higher levels of selected markers of inflammation and coagulation. These results suggest Lp(a) as a potential biomarker for CAC volume progression. (C) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据